Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label Extension Study of Patients Previously Enrolled in Study CIN-107-124 to Evaluate the Long-Term Safety and Effectiveness of CIN-107

NCT05459688 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT05459688
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05459688 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label Extension Study of Patients Previously Enrolled in Study CIN-107-124 to Evaluate the Long-Term Safety and Effectiveness of CIN-107
Lead sponsor
AstraZeneca
Phase
Phase 2
Overall status
Completed
Start date
April 6, 2022
Completion date
November 7, 2023
Enrollment
175 (actual)
Sites
36

Conditions

As the registry lists them; a condition with its own page is linked.

hypertension